Resultados de la búsqueda 81-90 of 1751 for Off-label

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel. Rochester, Minn., Jacksonville, Fla ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... away from work. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

6. Untitled

   Page 1. Page 2. Page 3.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... away from work. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from ...